share_log

Aptinyx Granted European Patent Titled 'Spiro-lactam Nmda Receptor Modulators And Uses Thereof (for The Treatment Of Conditions Such As Depression And Related Disorders)'

Aptinyx Granted European Patent Titled 'Spiro-lactam Nmda Receptor Modulators And Uses Thereof (for The Treatment Of Conditions Such As Depression And Related Disorders)'

Aptinyx 獲得名為「螺旋內酰胺 Nmda 受體調節劑及其用途(用於治療抑鬱症和相關疾病等條件)」的歐洲專利
Benzinga ·  2023/03/23 16:01

Aptinyx Granted European Patent Titled 'Spiro-lactam Nmda Receptor Modulators And Uses Thereof (for The Treatment Of Conditions Such As Depression And Related Disorders)'

Aptinyx 獲得名為「螺旋內酰胺 Nmda 受體調節劑及其用途(用於治療抑鬱症和相關疾病等條件)」的歐洲專利

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論